Table 1.
Factor | Unit |
Age | Years |
Sex | Male/female |
Previous smoker | Yes/no |
Current smoker | Yes/no |
Family CVD history | Yes/no |
Diabetes | Yes/no |
Abacavir treatment | Yes/no |
Protease inhibitor exposure | Years |
NRTI exposure | Years |
Time-updated CD4 cell count | Cells/µL |
Systolic blood pressure | mm Hg |
Total cholesterol | mmol/L |
HDL | mmol/L |
Estimation of the predicted 5-year risk is done using Cox models.
The full D:A:D model includes all the covariates listed above and is used when cumulative NRTI exposure is up to 10 years and PI exposure is up to 6 years. For individuals who are highly exposed to either NRTIs or PIs, a simpler D:A:D model is used to prevent overestimation of CVD risk. The simpler model excludes the covariates for abacavir treatment, PI and NRTI exposure times.
A more detailed explanation of the D:A:D equation is given in the online supplementary appendix 1.
CVD, cardiovascular disease; D:A:D, Data Collection on Adverse Events of Anti-HIV Drugs; HDL, high-density lipoprotein; NRTI, nucleoside reverse-transcriptase inhibitor; PI, protease inhibitor.